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Abstract 
   Several enzyme-linked immunosorbent assays (ELISAs) have been developed for 
the detection of antibodies to Corynebacterium pseudotuberculosis, the causative 
agent of caseous lymphadenitis (CLA). However, none are commercially available in 
the UK. It was therefore necessary to develop a new, economic ELISA for use in a 
research project studying the epidemiology of CLA in UK sheep. 
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19 The ELISA with its diagnostic qualities is presented. The ELISA was developed using 
sonicated C. pseudotuberculosis and optimised to detect total antibody or IgG class 
antibody in serum. Receiver Operating Characteristic (ROC) curves were obtained 
and the area under the ROC curve was used to compare the sensitivity and specificity 
of the two ELISAs.  
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   Both versions of the ELISA were evaluated on a panel of 150 positive reference sera 
and 103 negative reference sera. Using the test at 100% specificity, the sensitivity of 
detection of total antibody was 71% (95% confidence interval 63-78%), and the 
  2 
sensitivity of detection of IgG antibody to C. pseudotuberculosis was 83% (76-89%), 
which compares favourably with other reported ELISA tests for CLA in sheep. The 
sensitivity of the IgG antibody assay may be higher because of the greater affinity of 
IgG class antibodies compared with the IgM antibodies also detected by the total 
antibody ELISA. 
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   The results of ROC analysis indicated that the IgG isotype ELISA was more 
accurate than the total antibody ELISA. The efficiency of the test was greatest when 
serum samples were run in a dilution series than when any single serum dilution was 
used. The ELISA is considered to be suitable for application in field studies of CLA 
in UK sheep. 
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1. Introduction 
Corynebacterium pseudotuberculosis (formerly C. ovis) is the causative agent of 
caseous lymphadenitis (CLA) in sheep and goats. The disease is characterised by 
abscess formation in lymph nodes and/or viscera. In the UK, affected sheep typically 
have abscesses in the parotid or retropharyngeal lymph nodes, and the disease can be 
diagnosed by bacteriological culture of pus from such abscesses. However, a 
proportion of infected sheep may have only internal abscesses, often in the lungs or 
mediastinal lymph nodes, and show no overt clinical signs of infection. Identification 
of sheep with internal abscesses requires alternative diagnostic methods, and therefore 
researchers have developed serological tests for the diagnosis of CLA. 
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   CLA was first diagnosed in the UK in 1990, in imported Boer goats, and was first 
reported in sheep in this country in 1991. It has since spread widely within the UK 
sheep flock (Binns et al. 2002). CLA can cause economic losses for pedigree sheep 
breeders and concern has been raised that the disease may spread to commercial 
flocks and lead to an increased condemnation of lambs at slaughter. The true 
prevalence of infection in UK sheep has not been estimated, partly due to the lack of 
an adequate and available diagnostic test for infection in live sheep.  
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59    Although there are currently several serodiagnostic tests for the detection of 
antibodies to C. pseudotuberculosis in sheep, including haemolysis inhibition (Burrell 
1980), indirect haemagglutination, anti-haemolysin inhibition, complement fixation 
tests (Shigidi 1979), immunodiffusion (Burrell 1980) and enzyme-linked 
immunosorbent assays (ELISA), none are without problems (Sutherland et al. 1987). 
Various antigen preparations have been used in the ELISA tests, including cell wall 
antigens (Sutherland et al. 1987), crude exotoxin (phospholipase D) (ter Laak et al. 
1992; Dercksen et al. 2000), cell supernatant (Maki et al. 1985), and recombinant 
exotoxin (Menzies et al. 1994). 
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   Typically the tests perform adequately in goats (Dercksen et al. 2000; Kaba et al. 
2001), but with reduced sensitivity in sheep, especially in subclinically infected sheep 
with only internal abscesses. Tests may also have differing specificity when compared 
with bacteriological culture, possibly due to cross-reactions with related bacterial 
species or infected but recovered sheep (culture negative) or because of presence of 
maternal antibodies. Finally, the rate of seropositivity in culture-positive sheep varies 
with age and immune status and with the route and extent of exposure to C. 74 
pseudotuberculosis and the interval between exposure and diagnosis (Sutherland et al. 
1987).  
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The most specific diagnostic test reported for C. pseudotuberculosis is an ELISA 
based on recombinant phospholipase D (PLD) expressed in 
77 
E. coli (Menzies et al. 
1994). Perhaps the best current ELISA test is that developed for use in the Dutch CLA 
elimination and control programme (Dercksen et al. 2000). This modified double 
antibody sandwich ELISA has a sensitivity of 79 
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+ 5% and specificity of 99 + 1% for 
sheep. Neither of these ELISA tests are commercially available in the UK at present, 
and all those developed to date are relatively expensive. This paper describes the 
development of an alternative test used to for epidemiological research studies of 
ovine CLA in the UK.  
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2. Materials and Methods 
2.1 Sample collection and management 88 
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   Blood samples were collected from sheep by jugular venepuncture into 10 ml 
vacutainer tubes without anticoagulant (Becton-Dickinson). Serum was separated 
from clotted blood in vacutainers by centrifugation and decanting. Serum samples 
were aliquoted and stored at 4oC until processed; long-term storage was undertaken at 
–20oC. 
   To ascertain the true infection status of abscessed sheep in the positive reference 
sample, pus samples were taken from superficial abscesses of live sheep, or at post 
mortem examination from dead sheep, and transported in charcoal Amies’ transport 
medium to the laboratory. Bacteriological culture was carried out on blood agar under 
conditions of 5% CO2 for approximately 48 hours. Colonies morphologically 
resembling those of C. pseudotuberculosis were Gram-stained, and Gram-positive 
rods were tested for urease and catalase. Isolates that were urease and catalase 
positive were identified as 
99 
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C. pseudotuberculosis. A representative selection of 101 
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isolates was confirmed as C. pseudotuberculosis using the API-Coryne biochemical 
test system (Bio-Mérieux). 
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2.2 Reference serum samples 105 
106    The ELISA was evaluated on a panel of 150 positive reference sera from sheep in 
22 flocks, each sheep had at least one abscess positive for C. pseudotuberculosis at 
bacteriological culture at the time of sampling and 103 negative reference sera from 
sheep in four flocks which had never had a case of CLA. Many of the negative 
reference sera were obtained by one of the authors (LG) in 1993, before CLA had 
reached a high prevalence in the UK. 
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   A pooled positive control standard serum was prepared from all test sera with a 
relative antibody concentration higher than 0.8 times the highest positive serum 
sample in the positive reference collection (n = 28). Negative control standard sera (n 
= 3) were obtained from three one-year-old, barn-reared experimental Dorset sheep, 
which were determined to be free from lesions suggestive of CLA at post mortem 
examination. Bacteriological cultures of parotid and mediastinal lymph nodes from 
these sheep were also negative. 
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2.3 Antigen preparation  120 
121    The antigen used to coat the ELISA plates was obtained by growing up one bead 
from frozen stocks of an isolate of C. pseudotuberculosis obtained from an infected 
sheep (isolate 1620) in brain-heart infusion broth at 37
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oC with agitation for 48 hours. 
The culture was then centrifuged for 10 minutes at 2000 rpm; the cells were washed 
twice in 10 ml phosphate-buffered saline (PBS), and resuspended in 1.5 ml PBS. The 
cells were pulse sonicated (Soniprobe Type 1130A, Dawe Instrumental Ltd., London) 
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for six 30-second pulses to disrupt the cell walls. The antigen preparation was 
quantified using the Coomassie Blue method (Bradford 1976). Prepared antigen was 
stored in 1.5 ml aliquots at –20
127 
128 
129 
130 
131 
132 
133 
oC. Alternative antigen preparations that were initially 
tested included culture supernatant and non-sonicated cells, all antigens in either of 
these preparations were present in the sonicated cell preparation in preliminary 
experiments (unpublished data) and so the cell sonicate was used for further analysis.  
 
2.4 ELISA procedure and development  134 
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   Ninety-six well PVC microtitration plates (Greiner Bio-One Ltd., Stonehouse, 
Glos.) were coated with the sonicated bacteria at 4 μg/ml in 100 μl 
carbonate/bicarbonate buffer (15mM sodium carbonate, 35mM sodium bicarbonate) 
at a pH of 9.6, and incubated overnight at 4oC. The plates were washed between each 
incubation step three times in PBS-Tween (phosphate-buffered saline plus 0.1% v/v 
Tween-20) using a commercial plate washer (Titertek M384 Atlas Microplate 
Washer, Biological Instrumentation Services, Ltd.). Serum was added to the wells and 
the plates were again incubated overnight at 4oC. 
   Both versions of the ELISA used a two-step detection system; the primary detection 
antibody (mouse anti-sheep monoclonal) varied between the tests (see below), but the 
secondary detection was carried out using 100 μl of alkaline-phosphatase conjugated 
donkey anti-mouse IgG monoclonal antibody (Jackson Immunoresearch Ltd.) diluted 
to 1/1000 in PBS-Tween in all cases. Both detection antibodies were incubated on the 
plates at 37oC for one hour and then 50 μl per well alkaline phosphatase substrate p-
nitrophenol phosphate, disodium (1mg/ml) (Sigma) in carbonate/bicarbonate buffer 
was added. The plates were then left at room temperature to develop. The plates were 
read at 405nm against 492nm (non-specific absorption) when the highest standard 
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optical density (OD) reached 1.5-2.0 units on a Multiscan EX (Thermo Labsystems, 
Vantaa, Finland). The ELISA was optimised with respect to incubation times, and the 
concentrations of coating antigen and detection antibodies were optimised using 
chequerboard titrations.  
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2.5 Pan-light-chain ELISA 157 
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For this version of the ELISA, test sera were assayed using serial dilutions in 100 μl 
PBS-T against the positive standard, which was also run in serial dilutions. For each 
plate, 12 wells were filled with 100 μl PBS-T only, to serve as a background control. 
The primary detection antibody was the cell culture supernatant from cell line 
K67.3G2 supplied by Karin Haverson, School of Clinical Veterinary Science, 
University of Bristol. This monoclonal antibody detects ovine light chains, and 
therefore all antibody classes, and was diluted in PBS-Tween to 1/100 and added at 
100μl per well.  
 
2.6 Anti-IgG ELISA 167 
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For this version of the ELISA, test sera were tested at serial dilutions in 100 μl PBS-T 
starting at 1/100 against the positive standard. On each plate, 12 wells were filled with 
PBS only, to serve as a background control. The primary detection antibody used in 
this test was a monoclonal anti-ovine IgG (IgG1 plus IgG2) (clone VPM6, Serotec), 
diluted in PBS-Tween to 1/1000 (100μl per well).  
 
2.7 ELISA analysis 174 
175  
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Each of the sera were tested at a range of one in three dilutions; two negative standard 
control sera and the pooled positive standard (in duplicate) were also run in serial 
dilutions on each plate to provide positive and negative reference curves (serum 
dilution against OD). The process for calculating antibody concentrations relative to a 
standard has been previously described in several species (Finerty et al, 2000; Bailey 
et al, 2004;). Briefly, the mean background OD for completely negative wells was 
first subtracted from each OD reading. The concentration of antibody in the reference 
serum was arbitrarily assigned as 1. A graph was plotted of log[reference serum] 
against a transformed function for the OD. In this case, a square-root transformation 
of the OD produced the best straight line region within the curve. The intercept and 
gradient of this straight line region was calculated for each plate, and the values 
obtained used to calculate the amount of antibody in each well relative to the standard 
(equation 1).  
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[1] Concentration of antibody = gradient * OD0.5 + intercept 
 
Since each sample well contained a dilution of the original sample, the calculated 
relative[Ab] for each well was multiplied by the dilution to obtain a value for rel[Ab] 
in the original sample. Where rel[Ab] was calculated from multiple dilutions of a 
particular sample, only those dilutions whose OD values were within the linear part of 
the curve were used to obtain the mean and standard deviation (SD) of the rel[Ab]. 
This method required the assumption that the gradients of the line of log(dilution) 
against OD0.5 (usually a reflection of affinity) were the same for all samples: in fact, 
the gradients of some of the samples in the negative reference population were 
shallower, indicating low affinity 
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2.8 Statistical analysis 202 
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Statistical analysis was carried out using Stata version v.7 (Statacorp). The variables 
analysed were the antibody concentration relative to the positive standard over the 
linear portion of the dilution series (rel[Ab]) at each individual dilution for the anti-
IgG ELISA. Within- and between-assay repeatability was assessed by calculating the 
coefficient of variation for rel[Ab]. The agreement between test results was assessed 
by the calculation of the kappa statistic for the dichotomous value (positive or 
negative) using an appropriate cut-off, and Spearman rank correlation coefficients for 
the continuous variable (rel[Ab]) (Altman, 1991). The analysis of agreement was 
carried out for pairs of results using the same assay on different occasions, and using 
the two different ELISA tests. 
   Receiver Operating Characteristic (ROC) curves (plots of sensitivity against [1-
specificity]) were plotted and used to estimate the optimal cut-off for various values 
of sensitivity (Se) and specificity (Sp); the area under the ROC curve (AUC) was 
estimated by non-parametric integration (Greiner et al. 1995). Exact binomial 95% 
confidence intervals (or one-sided 97.5% CI for an estimate of 100% Se or Sp) for 
sensitivity and specificity were calculated. The mean and geometric mean relative 
antibody concentration were obtained for the positive and negative reference 
populations and tested using t-tests. Further measures of diagnostic test accuracy 
(Greiner et al. 1995) were estimated in an Excel spreadsheet. Odds ratios were 
corrected by adding 0.5 to each cell when Se or Sp was estimated to be 100%. The 
above analysis was carried out for each variable at cut-offs of 100% sensitivity, 100% 
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specificity, the maximum specificity with a sensitivity of > 80%, the maximum 
sensitivity with a specificity of 
225 
> 96%, and roughly equal sensitivity and specificity. 226 
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3. Results 
 
3.1 Distributions of the ELISA responses of reference sera 230 
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The geometric mean relative antibody concentrations, calculated for each dilution of 
sample independently, were significantly different between the positive and negative 
reference populations except for the two highest single dilutions using the anti-IgG 
ELISA system  (Table 1). This reflects the fact that at high dilutions, OD readings for 
positive and negative samples fall below the linear part of the curve and become 
unreliable, demonstrated by the increasing 95% confidence intervals relative to the 
mean. 
   The distributions of the relative antibody concentrations in each sample were 
negatively skewed, so logarithmic transformations were used in the analysis. 
Histograms of the logarithm of Rel[Ab] for both versions of the ELISA overlapped 
(boxed in Fig. 1 and 2) where the results of the positive and negative reference 
populations overlapped. This area was substantially narrower and involved fewer 
sheep for the anti-IgG ELISA (Fig. 1) than for the K67 ELISA (Fig. 2), indicating the 
greater efficiency of the former in discriminating between the two reference 
populations. 
 
3.2 Assessment of repeatability and inter-test and within-test agreement 248 
249  
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The within-assay (duplicate samples run at the same time, although rarely on the same 
plate) coefficient of variation (CV) was slightly lower than the between-assay 
(duplicate samples run on different occasions) CV (Table 2). The agreement for 
repeated assays within each version of the ELISA was acceptable (Table 3). However, 
the agreement between the K67 and anti-IgG versions of the test was lower, 
particularly in the positive reference population, indicating that the latter had 
increased sensitivity at 100% specificity compared with the former. 
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3.3 Cut-off determination and determination of sensitivity and specificity 258 
259 
260 
 
The sensitivity of the K67 test to detect total antibody and the anti−IgG test to detect 
IgG antibody to C. pseudotuberculosis was 71% (95% confidence interval 63-78%) 
and 83% (76-89%) respectively when the specificity was set at 100% (Table 4). The 
specificity of the K67 test was 23% (95% confidence interval 14-34%), and that of the 
anti−IgG test was 64% (53-74%) when the sensitivity was set at 100% (Table 4). 
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3.4 ROC analysis 266 
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   The results of ROC analysis indicated that the IgG isotype ELISA (AUC 0.9887) 
was more accurate than the total antibody ELISA (AUC 0.9494), P = 0.003. Using a 
1/100 dilution in the anti-IgG ELISA, the overall accuracy was not significantly 
different from that obtained using the whole series (AUC 0.9741, P = 0.2), but it was 
impossible to obtain 100% specificity using this dilution or the 1/900 dilution; the 
maximum specificity obtained in both cases was 98.9% (95%CI: 94.2-99.9%). 
 
4. Discussion 
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   The sensitivity and specificity of the anti-IgG ELISA compared favourably with 
other reported ELISA tests for CLA in sheep (Dercksen et al. 2000). The current 
ELISA was simpler and cheaper to run than the Dutch test which is an indirect 
double-sandwich antibody ELISA.  
275 
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   For a disease such as CLA, deciding a gold standard with high discriminatory 
efficacy is challenging. In the current study the gold standard used to define the 
positive reference population was culture of C. pseudotuberculosis from typical 
lesions. This is a reasonable positive standard. However, the assumption that negative 
culture is a negative control may not be valid. Many 
281 
282 
C. pseudotuberculosis-infected 
sheep do not display clinical signs, and lesions may be non-culturable rather than 
negative for 
283 
284 
C. pseudotuberculosis. It is impossible to be certain that the negative 
reference population is truly uninfected and has never been in contact with the 
bacterium (Menzies et al. 1994). We aimed to maximise our confidence of the status 
of our negative reference population by using a combination of sheep from clinically-
negative flocks, specific-pathogen-free sheep and experimental sheep that had never 
been in contact with CLA. If any of the negative reference population were infected, 
this would have resulted in misclassification, which in turn would bias the estimates 
of sensitivity and specificity (Staquet et al. 1981).  
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The representativeness of the negative reference population used for establishing the 
cut-off value is of major importance (Greiner and Böhning 1994). Negative samples 
ideally need to come from the same population as positive samples so that other 
biological factors within the target population can be ignored. In our case, the 
negative reference population were younger than the target population, and many of 
the samples were obtained in 1993, several years earlier than the current study field 
samples for which the ELISA was developed. This was done to ensure that the 
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negative control sheep were truly uninfected, but these factors are a potential 
limitation to the ELISA qualities. 
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   The ELISA presented in this paper was based on crude bacterial antigen, containing 
all the antigens in the cell supernatant and cell wall, to detect antibodies to as many 
antigens of C. pseudotuberculosis as possible, thus combining both cell-wall and 
toxin-based assays (Sutherland et al. 1987). Other authors have reported that a cell 
supernatant antigen performed better than sonicated cells (Maki et al. 1985) but this 
was not our experience. Muckle et al. (1992) reported that the specificity of crude 
antigen preparations was low, we addressed this by using a double antibody detection 
system and the specificity of our ELISA was reasonable. However, as demonstrated 
here the specificity of an IgG antibody test is higher than that of the total antibody 
ELISA for a given sensitivity, because the latter also detects IgM which may result in 
much greater cross-reactivity than with IgG alone.  
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   The ROC analysis was used to detect the best trade-off between sensitivity and 
specificity, to compare the accuracy of the two ELISAs and to investigate the use of 
single dilutions of test sera in the anti-IgG assay. The use of a series of dilutions of 
test sera was necessary initially to establish a cut-off point for the ELISA, to detect 
any prozone effect, and to identify a single serum dilution that could be routinely 
employed for test samples. The dilution series in fact proved more accurate than any 
single dilution of test sera in the anti-IgG assay. Most other reported ELISA tests for 
CLA use only a single serum dilution for each sample (Sutherland et al. 1987; 
Sutherland et al. 1987; ter Laak et al. 1992; Dercksen et al. 2000). The validation of a 
choice of one dilution against a series of dilutions is not described in these papers. 
However, such assays may have serious inaccuracies due to prozone effects at low 
dilutions and increasing errors at high dilutions (Figure 4). For the IgG ELISA 
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presented here the 1/100 dilution gave a similar AUC ROC to the dilution series, but 
it was not possible to obtain 100% specificity with this dilution. If this were not an 
important consideration, the test could be run using single 1/100 dilutions of test sera, 
resulting in a decrease in the cost of running the assay.  
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   A proportion of C. pseudotuberculosis culture-positive sheep were negative to our 
ELISA. This has been reported for all ELISAs developed to date. This is unlikely to 
be due to the particular infecting strain of 
329 
330 
C. pseudotuberculosis, because sheep 
experimentally infected with either sheep or goat strains of the bacterium showed 
similar responses on Western Blot analysis, and differed from the responses of 
identically-treated goats (Kamp et al. 2001). It is possible that some ‘false negative’ 
sheep did not produce antibody to the particular antigen(s) used, but this is less likely 
with crude antigen. It is also unlikely that infected sheep tested negative to the 
antibody-ELISA because they have lost antibodies because, although the half-life of 
experimentally-transferred antibody is only about three weeks, antibody can usually 
be detected for at least a year in natural infections. Even in sheep without gross 
lesions, it is likely that small quantities of antigen are sequestered by the follicular 
dendritic cells in lymph nodes, and that these periodically stimulate memory cells 
(KoscoVilbois and Scheidegger, 1995).  
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Although the immune response to CLA in most sheep has a strong humoral 
component (Pépin et al. 1993), it is possible that the low sensitivity of ELISA tests 
designed to detect antibodies to C. pseudotuberculosis may result from some sheep, or 
sheep during certain stages of infection, expressing a predominately cell-mediated 
immune response to the pathogen. In general, T
345 
346 
347 
348 
349 
H1 cells promote cell-mediated 
immunity (CMI) while TH2 cells stimulate a humoral immune response (Infante-
Duarte and Kamradt, 1999).  Genetic predisposition to express Th1 or Th2 responses 
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does occur in sheep and contributes to differences in the ability to control infectious 
agents (Gill et al, 2000). Some pathogens, such as 
350 
Mycobacterium avium subsp. 351 
paratuberculosis stimulate different arms of the immune response at different stages of 
pathogenesis (Burrells et al. 1998). Alternative techniques to identify diseased but Ab 
negative sheep include an ELISA to IFN-γ produced by stimulated leucocytes 
(Prescott et al. 2002) and polymerase chain reaction (Çetinka et al. 2002), but the 
feasibility of these techniques in diagnosing infection in live sheep on farms has not 
yet been demonstrated. 
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 The anti-IgG ELISA test reported here has since been used in epidemiology studies 
in the UK. The lack of sensitivity in individual sheep was overcome by increasing the 
sample size per flock, to ensure that if infection was present then it would be detected. 
An alternative would have been to reduce the cut-off value, resulting in an increased 
sensitivity at the expense of reduced specificity.  
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Table 1: Mean and geometric mean relative [Ab] (rel[Ab]) in positive and negative reference populations 
Relative [Ab] calculated 
using: 
Positive reference population 
geometric mean rel[Ab] (95% CI) 
Negative reference population 
geometric mean rel[Ab] (95% CI)  P-value (t-test) 
Total Ab*, all dilutions 0.19 (0.16-0.23) 0.022 (0.017-0.027) <0.001 
IgG#, all dilutions 0.14 (0.11-0.18) 0.007 (0.006-0.008) <0.001 
IgG, serum diluted 1/100 0.025 (0.024-0.027) 0.006 (0.005-0.006) <0.001 
IgG, serum diluted 1/300  0.057 (0.051-0.064) 0.009 (0.008-0.01) <0.001 
IgG, serum diluted 1/900 0.102 (0.087-0.12) 0.020 (0.019-0.022) <0.001 
IgG, serum diluted 1/2700 0.16 (0.13-0.19) 0.051 (0.048-0.054) <0.001 
IgG, serum diluted 1/8100 0.26 (0.22-0.30) 0.14 (0.14-0.15) <0.001 
IgG, serum diluted 1/24300 0.49 (0.43-0.56) 0.43 (0.40-0.45) 0.11 
IgG, serum diluted 1/72900 1.12 (1.03-1.21) 1.27 (1.17-1.38) 0.03 
*Total Ab: Total Antibody ELISA (K67) 
# IgG: anti-IgG ELISA 
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Table 2. Within- and between-assay coefficients of variation (CV): 
K67 ELISA Anti-IgG ELISA  
 
Sample: 
Median within-assay 
CV# (%) 
Median between-assay 
CV (%) 
Median within-assay 
CV (%) 
Median between-assay 
CV (%) 
Whole reference population  25.2 
IQ*: 12.7-34.3 
27.6 
IQ: 10.7-55.0 
19.6 
6.7-39.0 
30.2 
IQ:15.2-47.8 
Positive reference samples 19.9 
IQ: 8.5-34.3 
22.1 
IQ: 9.2-42.9 
Insufficient data 31.5 
IQ:15.2-49.3 
Negative reference samples 17.1 
IQ: 13.3-25.5 
50.4 
IQ: 26.8-95.6 
19.6 
6.7-39.0 
30.1 
IQ: 11.1-47.8 
#CV: Coefficient of variation 
*IQ: inter-quartile range 
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Table 3: Agreement between results of repeated applications of the same ELISA, and between results obtained with K67 and IgG 
ELISAs 
K67  Anti-IgG  Between K67 & IgG  
Sample: Kappa  
(P-Value) 
*Spearman 
(P-value) 
Kappa 
 (P-Value) 
Spearman 
 (P-value) 
Kappa 
(P-Value) 
Spearman 
  (P-value) 
Reference population 
(100% specificity)  
0.78 (<0.001) 0.87 (<0.001) 0.41 (<0.001) 
Reference population 
(100% sensitivity)  
0.60 (<0.001) 
0.91 (<0.001) 
0.62 (<0.001) 
0.93 (<0.001) 
0.49 (<0.001) 
0.77 (<0.001) 
Positive reference 
(100% specificity) 
0.76 (0.001) 0.86 (0.001) 0.67 (<0.001) 0.88 (<0.001) 0.22 (<0.001) 0.64 (<0.001) 
Negative reference 
(100% sensitivity) 
0.49 (0.002) 0.38 (0.006) 0.46 (<0.001) 0.78 (<0.001) 0.15 (0.14) 0.05 (0.79) 
*Spearman rank correlation coefficient 
  23 
Table 4: Accuracy at Specificity = 1 (97.5% lower confidence limit for specificity = 0.96; Positive predictive value = 1; Likelihood ratio 
of a positive test = 0) 
Rel[Ab] calculated using: Sensitivity  95% CI 
(sensitivity) 
Efficiencyc NPVd Youden’s Indexe LR-f Odds ratio 
(corrected) 
Total Aba, all dilutions 0.708 0.627-0.781 0.804 0.625 0.708 0.292 340.06 
IgGb, all dilutions 0.833 0.764-0.889 0.897 0.790 0.833 0.167 930.18 
IgG, serum diluted 1/100 Not obtained 
IgG, serum diluted 1/300  0.020 0.004-0.057 0.398 0.390 0.020 0.98 4.48 
IgG, serum diluted 1/900 Not obtained 
IgG, serum diluted 1/2700 0.587 0.503-0.666 0.749 0.607 0.587 0.413 267.62 
IgG, serum diluted 1/8100 0.207 0.145-0.280 0.512 0.441 0.207 0.793 49.82 
IgG, serum diluted 1/24300 0.193 0.133-0.266 0.504 0.437 0.193 0.807 45.89 
IgG, serum diluted 1/72900 0 0-0.024 0.385 0.385 -1 1 0.628 
aTotal Ab: Total Antibody ELISA (K67) 
b IgG: anti-IgG ELISA 
c Efficiency: (true positives + true negatives) / total 
d NPV: Negative predictive value 
eYouden’s Index: Se + Sp – 1 
fLR-: Negative likelihood ratio: [Probability of no disease/Probability of disease] given test result, divided by the odds [prevalence] 
gOdds ratio: Positive likelihood ratio / Negative likelihood ratio 
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Table 5: Accuracy at Sensitivity = 1 (97.5% lower confidence limit for sensitivity = 0.98; Negative predictive value = 1; Likelihood ratio 
of a negative test = 0) 
 
Rel[Ab] calculated using: Specificity 95% CI 
(Specificity) 
Efficiencyc PPVd Youden’s Indexe LR+f Odds ratio 
(corrected)g
Total Aba, all dilutions 0.229 0.137-0.344 0.748 0.727 0.727 1.296 87.50 
IgGb, all dilutions 0.638 0.533-0.735 0.861 0.815 0.815 2.765 527.84 
IgG, serum diluted 1/100 0.734 0.633-0.820 0.898 0.857 0.857 3.759 820.37 
IgG, serum diluted 1/300  0.511 0.405-0.615 0.812 0.765 0.765 2.043 313.95 
IgG, serum diluted 1/900 0.021 0.003-0.075 0.623 0.620 0.620 1.022 8.14 
IgG, serum diluted 1/2700 0 0-0.038 0.614 0.614 0.614 1 1.59 
IgG, serum diluted 1/8100 0 0-0.038 0.614 0.614 0.614 1 1.59 
IgG, serum diluted 1/24300 0 0-0.038 0.614 0.614 0.614 1 1.59 
IgG, serum diluted 1/72900 0.0106 0.0003-0.058 0.619 0.617 0.617 1.010 4.83 
aTotal Ab: Total Antibody ELISA (K67) 
b IgG: anti-IgG ELISA 
c Efficiency: (true positives + true negatives) / total 
d PPV: Positive predictive value 
eYouden’s Index: Se + Sp – 1 
fLR+: Positive likelihood ratio: [Probability of disease/Probability of no disease] given test result, divided by the odds [prevalence] 
gOdds ratio: Positive likelihood ratio / Negative likelihood ratio 
Rel[Ab] calculated using: AUC 
ROC 
Max Se at 
>0.96 Sp 
(95% CI) 
PPV NPV Max Sp at 
>80% Se 
(95% CI) 
PPV NPV Equal Se/Sp 
(95% CI Se) 
PPV NPV 
Total Aba, all dilutions 0.9494** 0.771  
(.69-.84) 
0.98 0.67 0.943 
(.86-.98) 
0.97 0.70 0.861 
(.79-.91) 
0.93 0.75 
IgGb, all dilutions 0.9887 0.933 
(.88-.97) 
0.98 0.90 1.0  
(.96-1.0) 
1 0.79 0.947 
(.90-.95) 
0.97 0.92 
IgG, serum diluted 1/100 0.9741 0.860 
(.79-.91) 
0.98 0.81 .968 
(.91-.99) 
0.98 0.81 0.940 
(.89-.97) 
0.97 0.91 
IgG, serum diluted 1/300  0.9677 0.887 
(.83-.93) 
0.98 0.84 0.98 
(.93-.99) 
0.98 0.75 0.920 
(.86-.96) 
0.95 0.88 
IgG, serum diluted 1/900 0.9372** 0.827 
(.76-.88) 
0.98 0.78 .989 
(.94-.99) 
0.93 0.41 0.887 
(.82-.93) 
0.92 0.83 
IgG, serum diluted 1/2700 0.8351** 0.673 
(.59-.75) 
0.97 0.66 0.585 
(.48-.69) 
0.76 0.68 0.747 
(.67-.81) 
0.83 0.66 
IgG, serum diluted 1/8100 0.6408** 0.387 
(.31-.47) 
0.95 0.50 0.287 
(.20-.39) 
0.65 0.49 0.573 
(.49-.65) 
0.69 0.47 
IgG, serum diluted 1/24300 0.4532** 0.193 
(.13-.27) 
0.94 0.43 0.850 
(.037-.16) 
0.59 0.22 0.400 
(.30-.51) 
0.52 0.30 
IgG, serum diluted 1/72900 0.3429** 0.093 
(.052-.15) 
0.82 0.40 0.351 
(.26-.46) 
0.67 0.53 0.633 
(.55-.71) 
0.74 0.52 
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**Significantly different (P < 0.05) from AUC ROC for αIgG series. 
Table 6: Results of ROC analysis 
aTotal Ab: Total Antibody ELISA (K67) 
b IgG: anti-IgG ELISA 
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Figure captions: 
Fig. 1: Histogram of Relative [Ab] for positive and negative reference serum samples: 
Anti-IgG ELISA. Box represents overlap between positive and negative reference 
populations 
 
Fig. 2: Histogram of Relative [Ab] for positive and negative reference serum samples: 
K67 ELISA. Box represents overlap between positive and negative reference 
populations 
 
Fig. 3: Receiver Operating Characteristic (ROC) curves for αIgG and K67 ELISAs 
   
Fig. 4: Sample data comparing sqrt(OD) against log(dilution) for standard (plus 
regression line) and two samples. Estimation of the concentration of sample 1 would 
be inaccurate from a single dilution of 1/100, while estimation of sample 2 would be 
inaccurate at a dilution of 1/1000. 
 
